← Back to headlines
Vertex passes key test in quest to treat kidney diseases
Vertex Pharmaceuticals said its drug for a rare kidney condition succeeded in a Phase 3 trial.
10 Mar, 15:03 — 10 Mar, 15:03
Sources
Showing 1 of 1 sources
Related Stories
Lurking dementia risk exposed by breakthrough test 25 years before symptoms
just now
HPV vaccination drive sees 81% coverage in four T.N. districts
11m ago
Melatonin: Everything you need to know about the popular sleep supplement
16m ago
Lea Ivančić Žic Peša explains neurodivergence: After the diagnosis, I stopped diminishing myself
17m ago